Sarah Gallois-Montbrun

Has grant

Research director (DR2)

INSERM
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Characterization of the cellular network involved in HIV-1 alternative splicing during infection

Open Date: 2021-04-01

Close Date: 2024-03-01

Grant: Close

Exploring the dynamic regulation of HIV-1 transcriptome during infection

Open Date: 2021-01-01

Close Date: 2023-12-01

Grant: Close

Identification of SARS-CoV-2 RNA binding proteins during viral replication

Open Date: 2021-01-01

Close Date: 2021-12-01

Grant: Close

Identification des partenaires cellulaires de la protéine Vif du VIH-1:uORF, inhibition traductionnelle d'APOEBC3G par Vif et réplication virale

Open Date: 2020-10-01

Close Date: 2021-10-01

Grant: Close

Les transcrits antisens du VIH-1: de nouveaux acteurs de la latence?

Open Date: 2019-03-01

Close Date: 2020-02-01

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Bone marrow stromal antigen 2 (BST2)/tetherin is a restriction factor that reduces HIV-1 dissemination by tethering virus at the cell surface. BST2 also acts as a sensor of HIV-1 budding, establishing a cellular antiviral state. The HIV-1 Vpu protein antagonizes BST2 antiviral functions via multiple mechanisms, including the subversion of an LC3C-associated pathway, a key cell intrinsic antimicrobial mechanism. Here, we describe the first step of this viral-induced LC3C-associated process. This process is initiated at the plasma membrane through the recognition and internalization of virus-tethered BST2 by ATG5, an autophagy protein. ATG5 and BST2 assemble as a complex, independently of the viral protein Vpu and ahead of the recruitment of the ATG protein LC3C. The conjugation of ATG5 with ATG12 is dispensable for this interaction. ATG5 recognizes cysteine-linked homodimerized BST2 and specifically engages phosphorylated BST2 tethering viruses at the plasma membrane, in an LC3C-associated pathway. We also found that this LC3C-associated pathway is used by Vpu to attenuate the inflammatory responses mediated by virion retention. Overall, we highlight that by targeting BST2 tethering viruses, ATG5 acts as a signaling scaffold to trigger an LC3C-associated pathway induced by HIV-1 infection.

Year:

2023

Collaborators (6)

Laurent Softic

INSERM

FRANCE
View details

Jean-Christophe Paillart

Research Director

CNRS Délégation Alsace

FRANCE
View details

Sandrine Belouzard

Centre National de la Recherche Scientifique (CNRS)

FRANCE
View details

Clarisse Berlioz-Torrent

Université Paris Cité

FRANCE
View details

Mary ARNOULD

Lecturer (Maître de conférences)

University of Montpellier

FRANCE
View details

Jean Dubuisson

Head of Laboratory

Institut Pasteur de Lille

FRANCE
View details